<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 07 Mar 2021 21:23:06 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>1.6亿美元！推动CAR-iT和CAR-iNK疗法进入临床，受拜耳青睐的细胞疗法领先公司完成C轮融资</title><link>https://mp.weixin.qq.com/s/EPrHpJ4SacqagD2Mq-8jjA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKSnFRn2biaET0FeGE9GQeeocYaIJAYM86upkCdVgv4LfJoAAa1QdbtWfsona4kqjiaucibhmshSCnIwA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Sun, 07 Mar 2021 20:58:35 +0800</pubDate></item><item><title>Science子刊揭秘胰腺癌新疗法：新型IL-17RB阻断剂，可有效延长小鼠寿命</title><link>https://mp.weixin.qq.com/s/YkvuVaAVBMNgdLEW8DPjwQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKQUYt0jz1kNbcg2IqJicZBTVicWU79Vcic8M3HzuU1cV3m7Cgtjko8tmiaOictticezcWfCzPHkqbNphlMQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Sat, 06 Mar 2021 21:04:19 +0800</pubDate></item><item><title>太抢手了！刚与默沙东签订18亿美元大单，这家NK细胞疗法公司又B轮融资1.2亿美元</title><link>https://mp.weixin.qq.com/s/U7jPvOjZIqTbk1KP7u4uCQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKSnFRn2biaET0FeGE9GQeeocAUhRXiaRVMnsxYl3vN1zy7jwyLkiaTo110FGmZjgOLBqyn5Vicic9LcW4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Fri, 05 Mar 2021 20:58:50 +0800</pubDate></item><item><title>主攻现货型CAR-T、CAR-NK疗法！诺奖得主公司C轮融资1.15亿美元，1个月前刚获艾伯维超3亿美元大单</title><link>https://mp.weixin.qq.com/s/XVYvNcmFgfwtRpbqbt9b4A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKQk7YTua8sibImWDdbmm8YQecXlfiaEFicbJLyrcpsXwCpcxECAibDYlLicbpG2S9OlWN2cr4OHehicf59w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Thu, 04 Mar 2021 21:01:02 +0800</pubDate></item><item><title>​Science同日发表3篇论文：成功靶向p53、RAS，新型双特异性抗体，来了！</title><link>https://mp.weixin.qq.com/s/lw5EFRYVjXKmv0ueJ53ULw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKTfbomVjcHbR2DJ1WsRJBkhibEm8MQYL7aia6BpfpslfFCxniaBvYWLTPX9oO2YicDJ70wllBJqBofIZA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Wed, 03 Mar 2021 21:02:27 +0800</pubDate></item><item><title>李苏昕点评 | 新一代纳米颗粒STING激动剂，激活时间延长至48小时，抗肿瘤效果显著更强</title><link>https://mp.weixin.qq.com/s/eThtPfoNyym3MAbiy7wgcw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKQAcsrLqoleESH29tCmibq9iaC2tNKBnicCPZJxicfc62hUynHP2PDhuq5WZ8e4xEib7keGuO1nlXicSXibA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Tue, 02 Mar 2021 21:00:38 +0800</pubDate></item><item><title>Nature深度报告：CAR-T疗法突破不断，这些新靶点最有希望</title><link>https://mp.weixin.qq.com/s/Kk12RNa6dAXgNlDk9JEn5g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKQAcsrLqoleESH29tCmibq9ia1q6K3bH6loRx1tMzGsrNGoQQVsOEn6ul8FG1dORFQbwbf5sqJjR5QA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Mon, 01 Mar 2021 21:05:38 +0800</pubDate></item><item><title>新版PROTAC技术，成功降解PD-L1</title><link>https://mp.weixin.qq.com/s/yq7Bxam7uI1KdYDy9opk6g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKS0ZrbA0lVfKkUYmW3c2VW6qyxf4RSgWrgCAicbA7aKtpz04Y1ahtkibWb0OtzOkeibL9NrVQwbKbdyA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>其实是一种双特异性抗体……]]></content:encoded><pubDate>Sun, 28 Feb 2021 20:59:37 +0800</pubDate></item><item><title>NK细胞疗法日渐火热：赛诺菲、默沙东等多家巨头抢滩，投资交易不断</title><link>https://mp.weixin.qq.com/s/7HF_UBxZR90fSbUMqZ5ozw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKR1icCibpj2WRZsqz6oibC586lwyRaicSqVoV7ic2BicpZwNNV4PJT16tESlyE2Brjjwicwov9l0ydE5icIdA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:18:53 +0800</pubDate></item><item><title>癌症免疫治疗“老兵”IL-2：研发回潮，能否续写PD-1神话？</title><link>https://mp.weixin.qq.com/s/9bPQKdj8ePjP8d_x-ahmGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/TlQib16c9wKSfGjOWIk7YaEnUYpgHVXJt3QkF7AlFE5awiaA6uLKmvVUjN9w6JicjUIbVYxJHRoDEsLYTJMyAMBxw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PD-1之前，它也曾众星拱月……]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:01:14 +0800</pubDate></item></channel></rss>